MeSH tree: E01.370.350.825
The international guidelines for diagnosing multiple sclerosis (MS), called the McDonald criteria, underwent their most significant overhaul in a decade in 2024. The internationally recognized framework is used to diagnose ...
Jul 16, 2026
0
10
Research led by a University of Sydney medical student could enable earlier and more accurate diagnosis of behavioral variant frontotemporal dementia—one of the most commonly misdiagnosed forms of early-onset dementia, which ...
Jul 14, 2026
0
4
World Cup fever has America in its grip as the international soccer tournament grinds steadily toward the final. But a new study highlights a darker side to the sport: the toll soccer can take on the brains of professional ...
Jul 13, 2026
0
60
Some people find it useful to talk through their problems—but language isn't necessary for logical reasoning, cognitive neuroscientists at MIT's McGovern Institute for Brain Research say.
Jul 9, 2026
2
79
New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with ...
Jul 9, 2026
0
4
One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to clinicians.
Jul 7, 2026
0
67
A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the ...
Jul 6, 2026
0
7
More than half the calories consumed by young kids in the U.S. come from ultra-processed foods.
Jul 2, 2026
0
8
For decades, neuroscientists have known that specific regions in the brain's left hemisphere are responsible for processing language. However, a new study by MIT researchers shows that language processing also occurs in many ...
Jul 1, 2026
0
15
Canada recently approved lecanemab to treat early Alzheimer's disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex. An article in the Canadian Medical Association ...
Jun 29, 2026
0
7
